Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT06761196
Recruiting Observational

Quality of Life After Breast Cancer Surgery

NCT06761196 · tracked via the Priya Life Science France tracker
Sponsor
Centre Hospitalier de Colmar
Phase
Observational
Started
2025-09-02
Last updated
2026-10-20

Condition(s) studied

Breast Cancer SurgeryQuality of Life

Investigational drug(s) / intervention(s)

Questionnaire

Questionnaire: The quality of life measured with different scales (BREAST-Q, EORTC QLQ C30 and BR42)

Study summary

The goal of this observational study is to prospectively collect data on quality of life after oncoplastic breast surgery.

Participants will be followed-up and answer quality of life questionnaire for a duration of 5 years after surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient aged 18 or over * Patient with breast cancer of any stage (including in situ) or healthy individual at high personal risk. * Patient requiring breast surgery under general anesthesia, whether for therapeutic or prophylactic purposes. * Patient capable, in the opinion of the investigator, of complying with the requirements and restrictions of the study. * Patient with a computer, tablet or smartphone connected to the Internet. * Patient followed in the center on a regular basis according to standard recommendations. Exclusion Criteria: * Patient requiring surgical intervention under local anesthesia only. * Patient requiring surgery for the installation or removal of an chemotherapy implantable port only. * Patients with a history of cancer other than breast cancer. Patients with a history of cancer more than three years old are eligible if they are treated and considered cured. Patients with a history of cervical carcinoma in situ or non-melanoma skin carcinoma are eligible. * Impossibility of being subject to regular monitoring for geographical, social or psychological reasons. * Patient under protective measure

Primary outcome measure(s)

  • Quality of life measured with BREAST-Q — From enrollment to the end of 5 years follow-up
    The BREAST-Q is a rigorously developed patient-reported outcome measure for use in cosmetic and reconstructive breast surgery and clinical practice. The BREAST-Q conceptual framework covers 2 domains: quality of life, and patient satisfaction. There is three independent modules developped for breast cancer (mastectomy, breast-conserving therapy, reconstruction). A conversion table is used to convert the raw scale summed score into a score from 0 (worst) to 100 (best). Higher scores reflect a better outcome.

Trial sites (1)

FacilityCityRegionStatus
Hôpitaux Civils de Colmar Colmar France Recruiting

More Centre Hospitalier de Colmar trials in France

Analysis of Factors Associated With Delayed Medical Consultation for Testicular Torsion Among Adolescents in the Haut-Rhin Department Between 2020 and 2025 Recruiting
Effect of Aromatherapy on the Management of Chemotherapy-Induced Neuropathy (CIN) Recruiting

Other trials for the same condition

Support and Post-therapeutic Rehabilitation for Women in Complete Remission of Breast Cancer in a Thermal Environment Active, not recruiting
Evaluation of the Quality of Life of Patients With DBB With the Installation of OPEP Recruiting
Evaluation of the Impact of Pilonidal Cyst Recurrence on Quality of Life in Patients Previously Treated With Conventional Surgery or Laser Therapy Recruiting
International CIPN Assessment and Validation Study Recruiting
QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters. Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06761196 on ClinicalTrials.gov ↗ ← All trials in France